New registry tracks stroke prevention without blood thinners
NCT ID NCT05565209
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 250 atrial fibrillation patients who received a left atrial appendage closure device to prevent strokes. The procedure blocks a small pouch in the heart where clots often form, allowing patients to avoid long-term blood thinners. Researchers will track how many patients have strokes or other clots over five years to see how well the procedure works in the long run.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Left atrial appendage closure device
What this could lead to
If successful, this study could confirm that left atrial appendage closure is a safe and effective long-term alternative to blood thinners for preventing strokes in atrial fibrillation patients.
What could go wrong
This is an observational registry, not a controlled trial, so results may not prove cause and effect. Long-term data collection may have missing or incomplete records.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR
RECRUITINGCréteil, 94010, France